PT936903E - Agente de efeito retardador - Google Patents

Agente de efeito retardador

Info

Publication number
PT936903E
PT936903E PT96931056T PT96931056T PT936903E PT 936903 E PT936903 E PT 936903E PT 96931056 T PT96931056 T PT 96931056T PT 96931056 T PT96931056 T PT 96931056T PT 936903 E PT936903 E PT 936903E
Authority
PT
Portugal
Prior art keywords
carrier material
product
water
polymer
active agent
Prior art date
Application number
PT96931056T
Other languages
English (en)
Inventor
Gunther Beisel
Original Assignee
Gunther Beisel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunther Beisel filed Critical Gunther Beisel
Publication of PT936903E publication Critical patent/PT936903E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT96931056T 1996-09-07 1996-09-07 Agente de efeito retardador PT936903E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/003950 WO1998009617A1 (de) 1996-09-07 1996-09-07 Mittel mit retardwirkung

Publications (1)

Publication Number Publication Date
PT936903E true PT936903E (pt) 2004-03-31

Family

ID=8166315

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96931056T PT936903E (pt) 1996-09-07 1996-09-07 Agente de efeito retardador

Country Status (11)

Country Link
US (1) US6541031B1 (pt)
EP (1) EP0936903B1 (pt)
AT (1) ATE251450T1 (pt)
AU (1) AU745722B2 (pt)
CA (1) CA2276283C (pt)
DE (2) DE29624397U1 (pt)
DK (1) DK0936903T3 (pt)
ES (1) ES2208761T3 (pt)
NZ (1) NZ336805A (pt)
PT (1) PT936903E (pt)
WO (1) WO1998009617A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210071A1 (de) * 1999-09-06 2002-06-05 Günther Beisel Mittel zur verbesserung und erhaltung der darmtätigkeit sowie verfahren zu dessen herstellung
CA2383996A1 (en) * 1999-09-06 2001-03-15 Gunther Beisel Agent for stimulating bowel function and method for producing the same
DE20023135U1 (de) * 2000-04-03 2003-04-03 Beisel, Günther, 40789 Monheim Mittel mit verbesserter Retardwirkung
WO2003002168A1 (en) * 2001-06-29 2003-01-09 Cook Biotech Incorporated Porous sponge matrix medical devices and methods
US6880570B2 (en) * 2003-08-14 2005-04-19 Delphi Technologies, Inc. Vehicle actuator
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
DE102004025495A1 (de) 2004-05-21 2005-12-15 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
US20100291266A1 (en) * 2009-05-15 2010-11-18 Tibor Czinki Natural Sponge Food and Regimen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435110A (en) * 1966-03-21 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
DE3429038A1 (de) * 1984-08-07 1986-02-20 B. Braun Melsungen Ag, 3508 Melsungen Wirkstoff-depot
WO1991017745A1 (en) * 1990-05-23 1991-11-28 Southwest Research Institute Filament system for delivering a medicament and method
DE4025912A1 (de) * 1990-08-16 1992-02-20 Werner Ratjen Mittel zur oralen einnahme
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
DE69433939T2 (de) * 1993-11-03 2005-08-11 Clarion Pharmaceuticals, Inc., Madison Hämostatisches pflaster
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE4419818C2 (de) * 1994-06-07 1998-10-22 Lohmann Therapie Syst Lts Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben

Also Published As

Publication number Publication date
AU745722B2 (en) 2002-03-28
US6541031B1 (en) 2003-04-01
EP0936903B1 (de) 2003-10-08
DK0936903T3 (da) 2004-02-09
CA2276283A1 (en) 1998-03-12
DE29624397U1 (de) 2003-02-20
ES2208761T3 (es) 2004-06-16
CA2276283C (en) 2009-12-22
ATE251450T1 (de) 2003-10-15
DE59610768D1 (de) 2003-11-13
AU6988696A (en) 1998-03-26
EP0936903A1 (de) 1999-08-25
WO1998009617A1 (de) 1998-03-12
NZ336805A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
CA2356860A1 (en) Osmotic delivery system having space efficient piston
ATE207374T1 (de) Implantat und applikationsvorrichtung
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
EE9800418A (et) Lahustuvad oksiidid bioloogiliseks kasutamiseks
GR3025333T3 (en) Cross-linking agent
DE69832050D1 (de) Implantatmaterial mit glaspartikeln
ES2058284T3 (es) Preparado capilar.
IT1230047B (it) Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
PT936903E (pt) Agente de efeito retardador
HK1020428A1 (en) Microencapsulated fluorinated gases for use as imaging agents.
NZ332950A (en) Wound dressing with lower section adjacent to wound to promote healing of wound, and upper section being permeable to vapor and impermeable to bacteria
ATE343364T1 (de) Verwendung von festen, gasifizierten teilchen für haarbehandlungen und diese enthaltendes haarbehandlungsmittel
EP1736170A3 (en) Agent for treating allergic or hypersensitivity condition
DE69105134D1 (de) Pharmazeutische zusammensetzung.
NZ331469A (en) A hand dryer and a method of disinfecting and deodorising the dryer and air emitted from it
ATE232120T1 (de) Arzneimittelträger für einen pulverinhalator sowie prozess zur herstellung desselben
Fourt Introduction to the symposium Adsorption from Blood or Tissue onto Foreign Surfaces Division of Colloid and Surface Chemistry, American Chemical Society Atlantic City, New Jersey, September 12 and 13, 1968
ATE310545T1 (de) Werkstoff zur herstellung von erzeugnissen mit fibrinolytischen und/oder antibakteriellen eigenschaften
RU95105648A (ru) Средство для лечения ран
RU96103969A (ru) Способ воздушной стерилизации и длительного хранения медицинских инструментов
TH18641B (th) วัสดุดูดซับรูพรุน ที่มีลักษณะของผิวที่ได้รับการดัดแปลงและวิธีสำหรับการทำ
MX9603475A (es) Materiales absorbentes porosos que tienen caracteristicas modificadas de superficie y metodos para hacer los mismos.
MX9603474A (es) Materiales absorbentes que tienen caracteristicas modificadas de superficie y metodos para hacer los mismos.